Will Obama tax reforms quash outsourcing?

Indian pharma companies worry that President Obama's tax plans could force U.S. drugmakers to cut back on outsourcing, which would cut into their contract manufacturing and API business substantially, the Times of India writes. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.